Sentante Secures €6 Million in New Funding to Revolutionize Endovascular Care
January 03, 2024
January 03, 2024
Sentante announces the closing of a €6 Million seed funding round led by Practica Capital with participation of EIC fund. The company will use the proceeds from the financing for the planned clinical trial of the Sentante robotic system and preparation of commercial launch in targeted international markets.
Read more here.
Our latest
news and publications
news and publications
-
Read
Sentante accepted into FDA Total Product Life Cycle Advisory Program following Breakthrough Device DesignationFebruary 13, 2026 -
Read
Sentante Accelerates Remote Stroke Surgery Innovation With First Live TrialsDecember 12, 2025 -
Read
Critical Stroke Procedure Performed from Across the AtlanticNovember 11, 2025